Drug alert: 35 drug samples fail to clear CDSCO test, 1 declared spurious

In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 35 medicine batches for failing to qualify for random drug sample tests for the month of April, while one drug sample has been declared spurious.

These drugs samples which are declared not of standard quality include Skymap Pharmaceuticals' Metopal – 50 XL (Metoprolol Succinate Extended Release Tablets IP), Alkem Health Science's Pantoprazole gastro- resistant and domperidone prolonged-release capsules IP Pan-D, Zee laboratories' Paracetamol oral suspension IP 60 ml. (for Paediatric use), Hindustan Antibiotic's Diclofenac Sodium Injection and others.

For more details, check out the link given below:

Drug alert:35 Drug Samples Fail To Clear CDSCO Test, 1 Declared spurious